Inogen
INGN | NASDAQ
$5.63
-$0.06 (-1.05%)
At close: Nov 16, 2026, 4:00 PM ET
$5.63
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-1.05%
(1D)No price chart data available for 1D timeframe.
Rating
42.5
Fundamentals Average
Market Sentiment Neutral
Moat Narrow
Sector Rank #459/1021 (Top 45%)
Key Statistics
Market Data
Market Cap $146.39M
1D Range
5.51 5.68
52W Range
5.09 7.35
Valuation (TTM)
PE -4.30
PB 0.93
EV/EBITDA -3.10
Valuation (NTM)
Forward PE N/A
Forward PEG -1.37
Price Target $26.00
Cash Flow
FCF Yield -11.6%
SBC Adj. FCF Yield -16.5%
SBC Impact -42.7%
Margins
Gross Margin 47.3%
Operating Margin -11.3%
FCF Margin -5.0%
Growth (CAGR)
Revenue 3Y | 5Y 1.1% |
-0.9%
Dil EPS 3Y | 5Y 30.9% |
26.0%
FCF 3Y | 5Y -6.6% |
20.9%
Returns
ROA -13.4%
ROE -20.1%
ROIC -19.2%
Financial Health
Net Cash
$81.91M
Current Ratio 2.96
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Inogen, Inc. operates as a medical technology enterprise dedicated to designing, fabricating, and distributing oxygen concentration equipment. These cutting-edge devices are engineered to provide cont...
Sector Healthcare
Industry Medical - Devices
Employees 753
IPO Date Feb 14, 2014
Website www.inogen.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 5, 2026
EPS
-$0.56
Miss -293.53%
YoY:
-180.00% REV
$77.19M
Miss -16.32%
YoY:
-16.45%Next Earnings
Feb 25, 2027
EPS Est
Pro
Rev Est
Pro
Add to Watchlist
Select watchlists to add or remove INGN